Antimullerian Hormone and Impending Menopause in Late Reproductive Age: The Study of Women's Health Across the Nation. Issue 9 (September 2020)

• Record Type: Journal Article
• Authors: Finkelstein, Joel S.; Lee, Hang; Karlamangla, Arun; Neer, Robert M.; Sluss, Patrick M.; Burnett-Bowie, Sherri-Ann M.; Darakananda, Karin; Donahoe, Patricia K.; Harlow, Sioban D.; Prizand, Sarah H.; Joffe, Hadine; Kumar, Ajay; Martin, Deborah E.; McConnell, Daniel; Merrilat, Steffenie; Morrison, Anthony; Pastore, Lisa M.; Randolph, John F.; Greendale, Gail A.; Santoro, Nanette
• Is Part Of: Obstetrical & gynecological survey. Volume 75:Issue 9(2020)
• Publication Date: 2020-09
• Subjects: Obstetrics -- Periodicals; Gynecology -- Periodicals; Generative organs, Female -- Surgery -- Periodicals; 618
• DOI: 10.1097/01.ogx.0000718760.78020.d2
• Languages: English
• ISSNs: 0029-7828

Abstract

Abstract : (Abstracted from J Clin Endocrinol Metab 2020;105(4):e1862–e1871) Follicle-stimulating hormone (FSH) is a widely used biomarker of ovarian age and indirectly of ovarian reserve; however, it has significant limitations. Antimullerian hormone (AMH) provides a more direct index of ovarian activity and remains at a stable level throughout the menstrual cycle, unlike FSH, allowing measurement at any time without affecting interpretation.